The investment round was co-led by Lakestar and Dawn Capital with participation from Temasek and Goldman Sachs.
"When we founded Eigen five years ago, I wanted build a research-led transatlantic business. Since the Series A we have made great progress by massively scaling the company, expanding our client base, and integrating cutting-edge machine learning techniques into our NLP product. This new round will allow us to supercharge our growth. 80-90% of the enterprise data in the world today is unstructured information such as text, meaning that most organizations are unable to it unlock its value. With continuing economic uncertainty and the ongoing disruption by data-native companies such as Google, Tencent, and Amazon the imperative to be able to leverage this data is stronger than ever. The new funding will enable Eigen to further its core mission by unlocking the value of our clients’ qualitative data. This will be underpinned by another big investment in our science team, which will double in size so that we can continue to stay at the forefront of machine learning research."
The Series B round was led by AO Proptech and Target Global with backing from Round Hill Ventures.
"It’s a massive market we operate in with very old systems in place. There are long-standing structural barriers that housing companies have to overcome in order to deliver a good tenant experience. By digitising the supply chain we’re creating a larger, more dynamic market of locally-available tradespeople and removing unnecessary manual processes, significantly improving the tenant or leaseholder experience."
The Series B round was led by Temasek and the Scottish Investment Bank to fund the development of mobile-ready LiFi components.
"Device manufacturers are looking for new ways to provide devices with faster, more reliable and secure connectivity. LiFi is the natural next step in the evolution of global wireless communications and pureLiFi is leading the way to provide this technology to the market."
The funding round was led by Summit Partners with participation from Goldman Sachs to support North American expansion.
"Gaps in cybersecurity knowledge meaningfully increase risk to an organization, creating vulnerability and presenting opportunity for attackers. The rapid, constantly evolving threat landscape has made traditional classroom training for cyber skills obsolete,"
The Series B round was led by Leaps by Bayer to support clinical studies and technology development.
"Medopad has a bold mission to help people live their life to the fullest – one that requires long-term commitment and partnership to achieve. We are delighted that Leaps by Bayer who participated in our Series A round have now become the lead investor in our Series B. We have found the ideal partner with the dedication to help us reach our vision of creating a world where each person lives their life to the fullest."
